We then used our gene expression data to find markers of therapy response. Because the response rates between ER+ and TN samples were vastly different (Table 1), analyses to detect biomarkers of ...
The ScBrAtlas spanned several stages of breast cancer genesis. First, reduction mammoplasties were obtained from women with no family history of breast cancer to explore cellular diversity in normal ...
A promising drug could lead to a new treatment for the most aggressive form of breast cancer, which affects thousands of women each year. A pre-clinical study led by the University of Adelaide found ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results